Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2005
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287195 Transdermal drug delivery systems
12/29/2005US20050287145 Compositions and methods for producing vascular occlusion
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2510823A1 Hemostatic compositions and devices
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609804A1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609798A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609504A1 T-type calcium channel blockers
12/28/2005EP1609482A1 Drug for treating hemophilia and method of treating hemophilia using the same
12/28/2005EP1608646A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
12/28/2005EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
12/28/2005EP1608311A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1367060B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/28/2005EP1246627B1 Polyanhydrides with biologically active degradation products
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0778836B1 Substituted 9-alkyladenines
12/28/2005EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
12/28/2005EP0705103B1 Use of notoginsenoside r1 for the treatment of endotoxin shock or heart diseases
12/28/2005CN1713919A Novel use of erythropoietin in heart diseases
12/28/2005CN1233613C Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233412C Preparation of polygelatine peptide injection
12/28/2005CN1233390C Chinese medicinal preparation of recreating blood for curing anaemia and producing method
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979554 polypeptide has an affinity for a phospholipid selected from a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylinositol, a phosphatidic acid, and a cardiolipin
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979445 Method for treating von willebrand's disease
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005120482A1 System and method for transdermal delivery of an anticoagulant
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282830 Use of dipyridamole or mopidamole for treatment and prevention of MMP-9-dependent disorders
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282808 activated blood coagulation factor X inhibitor; 5-Dimethylaminocarbonyl-3-[4-(N-formyl-N-methylamino)cyclohexylcarbonylamino]-N-(5-chloropyridin-2-yl)benzofuran-2-carboxamide; for treatment of thrombosis; free of phospholipidosis and/or hepatotoxicity; oral administration; bioavailability
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282735 Von Willebrand Factor (VWF); prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases requiring surgical procedures
12/22/2005US20050282730 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/22/2005US20050282277 Methods of increasing platelet and hematopoietic stem cell production
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050281784 Methods for administering recombinant adeno-associated virus virons to humans previously exposed to adeno-associated virus
12/22/2005CA2569170A1 Factor viia inhibitor
12/22/2005CA2568625A1 System and method for transdermal delivery of an anticoagulant
12/22/2005CA2565698A1 Benzimidazoles, method for producing them and the use thereof as drugs
12/21/2005EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome
12/21/2005EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
12/21/2005EP1606231A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions
12/21/2005EP1605968A2 Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides
12/21/2005EP1605954A1 A food-supplement composition suitable for promoting iron absorption
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1280567B1 Nitric oxide-releasing metallic medical devices
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005CN1711111A Thrombin-carrying bioabsorbable synthetic nonwoven fabric
12/21/2005CN1711104A An aqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboemb
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232297C Jiangjie blood supplementing mixture and its application
12/21/2005CN1232267C Medicine composition for treating cerebral vascular disease and its application
12/20/2005US6977270 Tocotrienolquinone cyclization product with an anti-hypercholesterol effect
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977249 molecular weight reduction of dextran by hydrolysis, hydrogenation, and oxidation; complexing with ferric oxy-hydroxide; narrow molecular weight distribution controlled by the ratio of hydrogenated/oxygenated groups; improved stability; anemia
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117920A1 Agent for removing factor causing circulatory dysfunction
12/15/2005US20050277660 Novel tetrahydroquinoline derivatives
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005CA2568801A1 Agent for removing circulatory dysfunction factor
12/14/2005EP1605049A2 Fibrinolytically active polypeptide
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1603920A1 Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
12/14/2005EP1603909A2 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1599715A3 Autologous or homologous coagulant produced from anticoagulated whole blood
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1482969A4 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequence
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 671